Key result
Shock-to-balloon time ≥120 minutes linked to ~59% higher mortality in VA-ECMO-supported AMI-CS patients.
Why the study?
The optimal timing of PCI in patients with acute myocardial infarction complicated by cardiogenic shock supported with VA-ECMO remains uncertain.
Does a shock-to-balloon time <120 minutes reduce all-cause mortality compared to ≥120 minutes in patients with AMI complicated by cardiogenic shock requiring VA-ECMO?
Cohort (n=256)
Yes
Does a shock-to-balloon time <120 minutes reduce all-cause mortality compared to ≥120 minutes in patients with AMI complicated by cardiogenic shock requiring VA-ECMO?
In patients with acute myocardial infarction complicated by cardiogenic shock requiring VA-ECMO, a shorter shock-to-balloon time (<120 minutes) is associated with significantly lower all-cause mortality.
Answers are grounded in this paper and cite their sources.
STB timing may influence outcomes in AMI-CS on VA-ECMO; leaves open optimal revascularization timing pending prospective trials.
The optimal timing of percutaneous coronary intervention (PCI) in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) who are supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO) remains uncertain. We aimed to evaluate the prognostic impact of shock-to-balloon time (STB) in AMI-CS patients supported with VA-ECMO before revascularization. This study included patient-pooled data from CS-dedicated registries, including the SMART-RESCUE and the SMC-ECMO. A total of 256 patients were included. Patients were stratified according to STB (<120 min, n = 140; ≥120 min, n = 116). Among the study population, all-cause mortality was significantly higher in the ≥120 minutes group compared with the <120 minutes group (65.2% vs . 44.6%; adjusted hazard ratio [HR]: 1.59, 95% confidence interval [CI]: 1.03–2.45, p = 0.037). This association was significant in the ST-segment elevation myocardial infarction (STEMI) subgroup (adjusted HR: 2.22, 95% CI: 1.26–3.93), and in patients with earlier (<60 min) VA-ECMO initiation (adjusted HR: 2.50, 95% CI: 1.42–4.38), whereas in the non-ST-segment elevation myocardial infarction (NSTEMI) subgroup a directionally consistent but nonsignificant trend was observed, without significant interaction ( p -for-interaction = 0.164). In AMI-CS patients who underwent VA-ECMO, a prolonged STB was associated with higher all-cause mortality, with a consistent but exploratory trend in NSTEMI. These findings support STB as a prognostic marker and warrant prospective evaluation of coordinated ECMO-revascularization pathways.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a cohort in Acute myocardial infarction with cardiogenic shock requiring VA-ECMO (n=256). Shock-to-balloon time ≥120 min vs. Shock-to-balloon time <120 min was evaluated on all-cause mortality (HR 1.59, 95% CI 1.03-2.45, p=0.037).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: